To elucidate the antitumor activity of the KPT-330 in the CTCL cells, we examined the efficiency of nuclear export and spatial expression of XPO1 protein and its target cargo proteins in KPT-330-treated cells. The gene discussed is XPO1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.